BOA™ Biomedical is a Miraki™ Innovation focused on infectious disease. Our mission is to provide governments, nurses, doctors and patients with innovative tools to fight the world’s most deadly infectious diseases and their outcomes including sepsis, hospital-acquired infections, antibiotic resistance, pandemic infections, pathogenic outbreaks, and the threat of bioterrorism. We have an exclusive global license to technology from the Wyss Institute at Harvard University. BOA’s platform manages infectious disease throughout the patient journey from diagnosis to tracking to treatment.
Company’s Keywords:
infectious disease, antibiotic resistance, covid19
<9
<
<2018
Your request has been submitted successfully.
Own or work here?